CMT and Atrophy

It’s Not Always CMT

DNA Nerve Image

Yes, CMT causes atrophy. There are three types of atrophy: physiologic, pathologic, and neurogenic. Atrophy is defined as tissue wasting caused by an external factor that acts independently of the tissue that’s wasting. Whereas dystrophy, on the other hand, is defined as tissue wasting caused by something happening within the tissue itself.

First and foremost, CMT is not a disease of muscle tissue. Yes, CMT causes muscle tissue to waste. However, muscle tissue wastes in CMT as a consequence of the disease within the nerves that control the muscles. Because the muscle tissue wastes as a result of diseased nerves, the wasting is medically defined as atrophy (the nerves are separate from the muscles that are wasting). By comparison, muscular dystrophy gets its name from muscle wasting as a direct result of the muscles themselves being diseased. For these reasons, CMT is not a type of muscular dystrophy, despite the MDA including CMT within its wheelhouse, as it does ALS and many other non-MD diseases.

What is physiologic atrophy? Physiologic atrophy is atrophy caused by not using the muscle enough. CMT can often lead to a sedentary lifestyle. In turn, this often leads to physiologic muscle atrophy. Physiologic muscle atrophy is also quite common with surgery. Muscle tissue lost from physiologic atrophy can be recovered through proper exercise, physical therapy, post-op surgery recovery, etc.

What is pathologic atrophy? Pathologic atrophy is usually seen with aging and malnutrition/starvation. Muscle tissue lost from pathologic atrophy is typically recoverable with proper diet and nutrition, proper exercise, and becoming more physically active.

What is neurogenic atrophy? Neurogenic atrophy is muscle atrophy that occurs with injury to, or disease of, the nerve that controls the atrophied muscle. This is the type of atrophy caused by CMT, and unfortunately, it is not recoverable. People who have CMT can have muscle atrophy for many reasons, and not all muscle atrophy someone may be experiencing is caused by CMT.

Somebody who has CMT can experience physiologic atrophy and pathologic atrophy. In CMT, any muscle loss not caused by neurogenic atrophy is still recoverable. For this reason, proper exercise and remaining as active as possible are essential. Should a muscle experiencing physiologic atrophy be overtaken by neurogenic atrophy, the lost muscle tissue will not be recoverable. It’s critically important in CMT to give the muscles as much of an advantage as possible. Proper exercise and remaining as active as possible together provide this needed advantage.

Updated: January 5, 2026 | By: K. Raymond

The Dorsal Root

More From The Dorsal Root


Close-up of a doctor’s hand holding a prescription pad while a patient’s wrist is wrapped with metal chains.


When Medicine Lost Its Compass

Evidence failed not because it was wrong, but because it was weaponized. I lived the downstream effects of that failure for more than a decade. This is what happens when medicine forgets that data always ends in a human being.


Illustrated graphic showing large ‘404’ numerals with people interacting with data screens and servers, alongside text reading ‘CMT Genetic Testing Error 404: Gene Not Found’ and ‘Examining Why Less Than Half of All Who Have Charcot-Marie-Tooth Disease Are Not Able to Obtain Genetic Confirmation of Their Disease.


Error 404: Gene Not Found

CMT genetic testing often fails to identify the cause of the disease, even when comprehensive panels are used. Here, we discuss why this happens, what genetic tests can and cannot do, and why a negative result still matters.


Illustrated cover graphic showing a split landform with branching directional arrows, two people with question marks above their heads, and the title ‘SORD Deficiency: Decoding This Newly Discovered and Confusing CMT Subtype.


CMT-SORD: What Is This Unique CMT Subtype?

CMT-SORD is a newly discovered CMT subtype driven by toxic sorbitol accumulation. This article explains how "SORD" works, why this subtype is different, and how it led to the fastest-moving therapeutic program in CMT history.